Cargando…

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

BACKGROUND: To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, As...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borobia, Alberto M, Carcas, Antonio J, Pérez-Olmeda, Mayte, Castaño, Luis, Bertran, María Jesús, García-Pérez, Javier, Campins, Magdalena, Portolés, Antonio, González-Pérez, María, García Morales, María Teresa, Arana-Arri, Eunate, Aldea, Marta, Díez-Fuertes, Francisco, Fuentes, Inmaculada, Ascaso, Ana, Lora, David, Imaz-Ayo, Natale, Barón-Mira, Lourdes E, Agustí, Antonia, Pérez-Ingidua, Carla, Gómez de la Cámara, Agustín, Arribas, José Ramón, Ochando, Jordi, Alcamí, José, Belda-Iniesta, Cristóbal, Frías, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233007/ https://www.ncbi.nlm.nih.gov/pubmed/34181880 http://dx.doi.org/10.1016/S0140-6736(21)01420-3

Ejemplares similares

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
por: García-Pérez, Javier, et al.
Publicado: (2022)

No changes in hemostasis after COVID-19–heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study
por: Butta, Nora V., et al.
Publicado: (2023)

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
por: Ascaso-del-Rio, Ana, et al.
Publicado: (2022)

T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
por: Zenarruzabeitia, Olatz, et al.
Publicado: (2021)

Efficacy and Usability of eHealth Technologies in Stroke Survivors for Prevention of a New Stroke and Improvement of Self-Management: Phase III Randomized Control Trial
por: Ortiz-Fernández, Leire, et al.
Publicado: (2019)

Consultor Combi visual
Publicado: (1992)

Consultor Combi visual
Publicado: (1988)

Enciclopedia Combi visual
Publicado: (1976)

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
por: Neuhann, Julia M., et al.
Publicado: (2022)

Beam-beam interactions with COMBI
por: Van Daalen, Tal
Publicado: (2015)

2383. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised trial in adults ≥75 years (EU-COVAT-1) from the VACCELERATE consortium
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation
por: García-García, Irene, et al.
Publicado: (2021)

Predictive engines based on pharmacokinetics modelling for tacrolimus personalized dosage in paediatric renal transplant patients
por: Prado-Velasco, Manuel, et al.
Publicado: (2020)

Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol
por: Monserrat Villatoro, Jaime, et al.
Publicado: (2020)

Enhancing the multi-dimensional assessment of quality of life: introducing the WHOQOL-Combi
por: Skevington, Suzanne M., et al.
Publicado: (2020)

Health Care Workers’ Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study
por: Borobia, Alberto M, et al.
Publicado: (2021)

Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance Program
por: Muñoz, Raúl, et al.
Publicado: (2016)

La participación infantil en las actividades productivas de México /
por: Pérez García, María Jesús
Publicado: (2017)

CombiANT: Antibiotic interaction testing made easy
por: Fatsis-Kavalopoulos, Nikos, et al.
Publicado: (2020)

Cross-Linked Enzyme Aggregates and Their Application in Enzymatic Pretreatment of Microalgae: Comparison Between CLEAs and Combi-CLEAs
por: Blanco-Llamero, Cristina, et al.
Publicado: (2021)

DeepCOMBI: explainable artificial intelligence for the analysis and discovery in genome-wide association studies
por: Mieth, Bettina, et al.
Publicado: (2021)

P19-36. Preclinical study of CombiHIVvac vaccine
por: Kaplina, O, et al.
Publicado: (2009)

Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy
por: Karpenko, Larisa I., et al.
Publicado: (2017)

Violence in first-episode psychosis: evidence from an early intervention in psychosis programme
por: Mentxaka, Oihane, et al.
Publicado: (2023)

Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
por: Arana-Arri, Eunate, et al.
Publicado: (2017)

Nutrition, a health technology that deserves increasing interest among HTA doers. A systematic review
por: Gutiérrez-Ibarluzea, Iñaki, et al.
Publicado: (2015)

Glucose Biosensor Based on Disposable Activated Carbon Electrodes Modified with Platinum Nanoparticles Electrodeposited on Poly(Azure A)
por: Jiménez-Fiérrez, Francisco, et al.
Publicado: (2020)

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
por: García-García, I., et al.
Publicado: (2021)

Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years
por: Borobia, Alberto M., et al.
Publicado: (2017)

An Acenocoumarol Dosing Algorithm Using Clinical and Pharmacogenetic Data in Spanish Patients with Thromboembolic Disease
por: Borobia, Alberto M., et al.
Publicado: (2012)

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score
por: Berenguer, Juan, et al.
Publicado: (2021)

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
por: Pérez-Rodríguez, Sonia, et al.
Publicado: (2022)

Acute Poisoning Readmissions to an Emergency Department of a Tertiary Hospital: Evaluation through an Active Toxicovigilance Program
por: Muñoz Romo, Raúl, et al.
Publicado: (2022)

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
por: Gutiérrez-Gutiérrez, Belén, et al.
Publicado: (2021)

Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV
por: Motta, Edwiges, et al.
Publicado: (2023)

The how’s and what’s of vaccine reactogenicity
por: Hervé, Caroline, et al.
Publicado: (2019)

Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies
por: Rodriguez-Pascual, Jesus, et al.
Publicado: (2019)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

Effectiveness of immunosuppression minimisation, conversion or withdrawal strategies in paediatric solid organ and haematopoietic stem cell transplantation: a protocol of a systematic review and meta-analysis
por: Martin Saborido, Carlos, et al.
Publicado: (2020)

Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty(®) vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)
por: Risco-Risco, Carlos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_57vjb9rus8c9lgv3n1s93b7m8p